https://www.selleckchem.com/pr....oducts/abraxane-nab-
3 and 91.2% respectively. 1-year and 5-year survivals in Group 1 was 96.7%, and 93.1%, whereas Group 2 was 94.6 and 90.1% with no statically significantly difference between the two groups ( = 0.59). Percutaneous intervention results are good in patients having bilirubin up to 6 mg dl , . mild to moderate liver dysfunctions. Technical success, survival and outcome of percutaneous intervention in BCS patients having serum bilirubin 3-6 mg dl was comparable to patients having bilirubin level 3 mg dl . Percutaneous inte
Like
Comment
Share
